FNY Partners Fund’s AbbVie ABBV Stock Holding History

FNY Partners Fund’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,800	Closed	-$248K	–	419
2017 Q3	$248K	Buy	+2,800	New	+$213K	0.04%	159

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

FNY Partners Fund's ABBV Position: Q4 2017 in Review

FNY Partners Fund sold out of AbbVie (ABBV) in Q4 2017, closing a stake of 2,800 shares — an estimated $248K sold.

FNY Partners Fund first reported a position in ABBV in Q3 2017 and held it in 1 quarter. The position peaked at $248K in Q3 2017. 2,001 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

FNY Partners Fund reported no remaining AbbVie position as of Q4 2017 after selling out during the quarter.
FNY Partners Fund sold 2,800 AbbVie shares in Q4 2017, an estimated $248K.
FNY Partners Fund first reported a position in AbbVie in Q3 2017 and held it in 1 quarter.
FNY Partners Fund's AbbVie position peaked at $248K in Q3 2017.
2,001 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on FNY Partners Fund's 13F filing for Q4 2017, filed 24 Jan 2018.